Back to Results
First PageMeta Content
Pharmacology / Stimulants / Attention-deficit hyperactivity disorder / Piperidines / Organochlorides / Methylphenidate / Guanfacine / Adderall / Dexmethylphenidate / Medicine / Chemistry / Nootropics


Pediatric Focused Safety Review: INTUNIV® (guanfacine hydrochloride XR) Pediatric Advisory Committee Meeting May 16th , 2011 Hari Cheryl Sachs, M.D., FAAP; Team Leader
Add to Reading List

Open Document

File Size: 176,63 KB

Share Result on Facebook

Company

Shire Pharmaceuticals Inc. / /

Event

FDA Phase / /

IndustryTerm

guanfacine-containing products / /

MedicalCondition

Syncope / ADHD / Bradycardia / Hypotension / /

MedicalTreatment

adjunctive therapy / /

OperatingSystem

OSE / /

Organization

New Drugs Center for Drug Evaluation / Food and Drug Administration / Maternal Health Staff Office / Pediatric Advisory Committee / /

Person

Pediatric Labeling / Hari Cheryl Sachs / /

Position

Team Leader / /

Product

guanfacine hydrochloride / Ritalin LA / Concerta / Adderall XR / Tenex / Vyvanse / Focalin XR / Metadate CD / Metadate CD® / INTUNIV / INTUNIV® (guanfacine XR) / /

SocialTag